[Pharmagological properties of isonitrosine and its antidotal effect in phosphoorganic poisoning].
D000818:Animals; D000931:Antidotes / Q000627:therapeutic use*; D001921:Brain / Q000201:enzymology; D002415:Cats; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D002802:Cholinesterases / Q000097:blood; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D007306:Insecticides / Q000506:poisoning*; D007531:Isoflurophate / Q000506:poisoning; D008297:Male; D051379:Mice; D008916:Miotics / Q000494:pharmacology / Q000506:poisoning; D009603:Nitroso Compounds / Q000097:blood / Q000506:poisoning* / Q000627:therapeutic use / Q000633:toxicity; D010710:Phosphates / Q000506:poisoning*; D010721:Phosphinic Acids / Q000506:poisoning
D000931:Antidotes; D002800:Cholinesterase Inhibitors; D007306:Insecticides; D008916:Miotics; D009603:Nitroso Compounds; D010710:Phosphates; D010721:Phosphinic Acids; D007531:Isoflurophate; D002802:Cholinesterases
Farmakolicheskie svoĭstva izonitrozina i ebo antidotenoe deĭstvie pri otravlenii fosfororganicheskimi soedineniiami.